Picture of 2nd Annual Medical Devices Summit West

2nd Annual Medical Devices Summit West


Reducing Risk and Increasing Return through Cutting-Edge Business Strategy and Technological Innovation
June 7-8, 2012
DoubleTree by Hilton Hotel San Diego - Mission Valley
San Diego, CA
United States

Bookmark and Share
Untitled Document
Conference Details
Join industry professionals from across the globe for this year's Medical Devices Summit West! With many device companies feeling the stress of increased scrutiny and regulatory hoops to jump through, many feel that innovation is being stifled. That is not only hurting the medical device industry, but greatly impacting consumers and the global healthcare market.

The only way to push the envelope of innovation is by sharing new ideas, promoting novel technologies, and working together on strategies for fostering development. Join us for discussions on the most cutting edge software and devices on the market, and most importantly- learn how they got there, and what they're doing to stay ahead!

Attendees will be given the opportunity to work closely with thought leaders to share ideas, experiences and strategies- while working towards a common goal of truly revolutionizing the medical devices industry.
Speaker Faculty

Jeff Hersh, Chief Medical Officer, HealthCare Systems, GE Healthcare
David Hankin, CEO, Alfred E. Mann Foundation for Scientific Research
Aaron Goldmuntz, Senior Director, Business Development and Strategy, West Wireless Health Institute
Dr. Marvin Slepian, Co-Founder and Chairman, SynCardia
Adam Schlifke, MD, MBA, Anesthesiologist,Kaiser Permanente; Entrepreneur, Panaceon & IdeaMed; Mentor, Blueprint Health
David M. Cronin, CEO, Cognition Corporation
Dan Sterling, President, Sterling Medical Devices
Arundhati Parmar, Bureau Chief, MedCity News Dr. Eric Maass, Senior Master Black Belt and Senior Program Manager, DFSS / DRM, Medtronic Anette Asher, Board of Directors, Sharp Healthcare & HIMSS
Christopher Lindop, Interoperability Manager, GE Healthcare
Michael Preston Taborn, Platform Architect, Medical Segment, Embedded & Communications Group, Intel Corporation
Amir Raz, Senior Product Manager, Test Management, Wind River
Dinesh N. Melwani, Attorney, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
Leslie I. Bookoff, Attorney, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
Nena Bains, Vice President, Intellectual Property & Legal Affairs, Asthmatx, Inc., a Boston Scientific Company
Georgette Belair, Executive Director of R&D: Functional Bracing and Soft Goods, Ossur
Lucia Buehler, Group Product Director, AlphaTec Spine
Rob Pecsar, Vice President of R&D, CareFusion
Dr. Christopher J. Devine, President, Devine Guidance, & Former Senior Manager of Corporate Quality Assurance, Boston Scientific
Laurie Weberman-Roussel, Senior Director and Counsel - International, Boston Scientific Corporation
Zachary Woodson, Senior Regulatory Affairs Manager, Medtronic Vascular
Dale Hallerberg, Technical Manager, Medical Product Testing, TUV Rheinland Wayne Ariola, Vice President of Strategy, Parasoft Todd Boone, Director of Open Innovation, Psion
Skip Coomber, Angel Investor; Chairman, HEROware
Mark Bates, Chief Executive Officer and Founder, Nexeon MedSystems
Jeff J. Garg, Executive Leader, Global Director, Supply Chain & Strategic Sourcing, Ossur Americas

Online Hotel Reservations

Target Audience:
Medical Devices Manufacturing Companies - Manager/ Engineers/Director/ VP of:
  • Product Design
  • Marketing
  • R&D
  • Business Development
  • Engineering
  • Software
  • And anyone who is truly interested in the future of Medical Devices!
Hotel Info:
Double Tree by Hilton Hotel San Diego - Mission Valley
7450 Hazard Center Drive
San Diego, CA 92108

We are pleased to announce that the Opal room block is open and we are accepting reservations. Please click on the ONLINE HOTEL RESERVATION link to book your room. The hotel will not accept individual call-ins.
Online Hotel Reservations
  • Rooms are available only to those participants who are registered conference attendees.
  • Rooms will not be guaranteed without a credit card.
  • Rooms are allocated on a first come first serve basis. Room types/rates are subject to availability.
  • The name on the form will be the name of the guest room.
Conference Registration Prices:
Early Bird Rate
(Expires 4/20/12)
Standard Rate
Service Providers
$795
$995
Medical Device Companies, Academia, Government *
First 100 free*, after $495
Register Now!
Group Discounts:
Register 3 people and receive 10% off ***
Register 4 people and receive 15% off ***
Register 5 people or more and receive 20% off ***

If you'd like to be invoiced, please submit your contact details on the registration page and select "Please invoice me" at the bottom of the page.

If you are interested in sponsorship, exhibiting, or speaking opportunities, please call 212-532-9898 or email information@opalevents.org
* TERMS & CONDITIONS
Subject to approval. To qualify you must be currently employed by a non-vendor company.Eligibility will be verified by Opal. Opal reserves the right to allocate places and to refuse applications or to charge a normal attendance fee once the number of complimentary places has been exceeded.

* Excluding contract manufacturers and other service providers


Registration price reflects $100 online discount
Platinum Sponsor:
Cognition
Gold Sponsors:
Intel Wind River
Silver Sponsors:
Finnegan ISIS SGSSterling Smartware Solutuions
Roundtable Sponsors:
ParasoftPsion TUVRheinland
Exhibitor Sponsors:
DTx LDRA Product Creation Studio
General Sponsor:
Lychron Nitrogen SF
Media Partners:
Bvents.comCutting Edge Info Fierce Medical Devices Going to MeetGreen Conduct Medical Billers and Coders Medical Electronic Device SolutionsPharm Cast PharmaPhorum
Untitled Document
2012 Attendees:

President, 1800 Medicine
Field Service Engineer Supervisor, Abbott
Group Leader, Abbott
Research Associate, Abbott
Senior Supplier Engineer, Abbott
VP R&D, Abbott
Director of Quality and Regulatory Affairs, Acumed
Assistant Scientist, Advanced Sterilization Products
Assistant Scientist, Advanced Sterilization Products
Director of Healthcare Strategy, Aerocrine, Inc
CEO, Alfred E. Mann Foundation
Director of Scientific Research, Alfred E. Mann Foundation
Senior Product Manager, AliMed
CEO, All Clear Diagnostics
Compliance & Training, Allergan
Group Product Director, Alphatec Spine
Senior Field Engineer, Amendia
Executive Director, Amgen
Associate Director of Corporate Quality, Amylin
Senior Analyst, Product Support, Amylin
Senior Director of Corporate Quality, Amylin
Lead Analyst, Quality, Amylin
Associate Director, Product Complaints, Amylin
Document Systems Supervisor, AngioDynamics
Software Manager, Applied Medical
CEO, Aquavit Pharmaceuticals, Inc
Director of Operation, Aramark
Associate Professor, Arizona State University
Director of Sales Operations, Arstasis Inc
Scientist, ASP
Director R&D, Aspen Medical Products
Vice President, Intellectual Property & Legal Affairs, Asthmatx
CEO, Avacen
SVP Strategic Marketing, Avera McKennan Hospital & University Health Center
Principal Quality Engineer, Baxter Healthcare
Community Relations Director¸ Bay Area Vital Link
Senior Product Manager, BD Medical
Group Manager, Service, Beckman Coulter
Global Field Service Executive, Beckman Coulter
Quality System Assessment Specialist, Beckman Coulter
General Manager, Beevers Manufacturing
General Manager, BioCells America
CEO, Bioelectric Research Corporation
Director of Research and Development, Bioelectric Research Corporation
VP Operations, Director-Business Development, Biolink
Regional Business Director, BioSense Medical Devices
Senior Director and Counsel: International, Boston Scientific
President, Calmar Orthopedics
Algorithm Development Engineer, Cameron Health
Director of Research, Cameron Health
Technical Services Manager, Cameron Health
Sales Development Manager, Canon
Electrical Engineer, CareFusion
Interaction Designer, CareFusion
Interaction Designer, CareFusion
Director Product Engineering, CareFusion
Manager of Interaction Design, CareFusion
Principal Electrical Engineer, CareFusion
Principal Electrical Engineer, CareFusion
Principal Mechanical Engineer, CareFusion
Regulatory Quality Engineer, CareFusion
Senior Electrical Engineer, CareFusion
Senior Regulatory Quality Engineer, CareFusion
Senior Mechanical Engineer, CareFusion
Senior Principal Engineer, Hardware Quality, CareFusion
Vice President of R&D, CareFusion
Policy Advisor, CDRH
Associate, Cedar Sinai Hospital
President, Cerora
CEO, ClariTrac
Application Engineer, Cognition Corporation
CEO, Cognition Corporation
Sales Representative, Cognition Corporation
Vice President of Customer Success, Cognition Corporation
Sales Administration, Compression Solutions
Director, Corporate Channels
Software Engineer¸ Darkhovsky
CEO, DD&S
Board of Directors, DARTNet Institute
Partner, Deloitte
President, Devine Guidance
Vice President of Product Development, Digirad
Representative, DTx
SVP, General Manager, Dudnyk
Business Development Manager, Eigen
Vice President of Strategy and Operations, Eigen
Vice President and Global Business Relations Leader, Epic-Medical
CEO, FindCure.org
Attorney, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
Attorney, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
COO, First Pulse Medical
CEO, First Pulse Medical
Consumer Safety Officer, FDA
QS Complaint Manager, Fresenius
Attorney, Frommer Lawrence and Haug
CEO, Four Corners Development Group
Senior VP Global QA/RA, Gambro Renal Products
Chief Medical Officer, GE Healthcare
Interoperability Manager, GE Healthcare
Principal Engineer, GE Healthcare
Senior Sales Manager¸ GE Healthcare
Director, Gen-Probe
Senior Software Quality Engineer, Haemonetics
Controls Engineer, Hansen Medical
Product Support Engineer, Hansen Medical
CEO, Hemacon
Angel Investor and President, HEROware
Director, Hitachi High Technologies America
Senior Manager, Hitachi High Technologies America
Associate Director, Regulatory Affairs, Hospira
Engineer, IMER
Manager of Regulatory Affairs, Innovasis
Platform Architect, Medical Segment, Embedded & Communications Group, Intel Corporation
President, International Biomedical
Director, Intricon
CEO, Invoy Technologies
Director of Engineering, Invoy Technologies
Senior IP Counsel, Invoy Technologies
Business Development Manager, Isis
Tradeshow Coordinator, Isis
Senior Associate Scientist, Janssen
Group Leader, Johnson and Johnson
Area Director of Sales, Karl Storz Endoscopy America
Manufacturing Engineer, Karl Storz Endoscopy America
Representative, Karl Storz Endoscopy America
Administrative Director, Health Technology and Engineering Program: Keck School of Medicine
Partner, Lahtif Precision Group
Partner, Launch Global
Biomedical Engineer, Life Instruments

Director of Global Quality, Life Technologies
CEO, LifeConnect Capital Holdings LLC
Executive Director of Sales, LifeConnect Home Services LLC
Founder, Exec. Chairman, LifeConnect Capital Holdings LLC
COO, Lifeline2me
Director, LightBio
CEO, LightScan Technologies
Director, Lightscan Technologies
CEO, LifeStim
President, LifeStim
Representative, LightScalpel
CEO, LSIT Global
Senior Mechanical Engineer, Maquet Cardiovascular
VP Design, Masimo
Bureau Chief, MedCity News
International Sales, Medical Illumination
Sales and Marketing Director, MEDRAD
Field Clinical Engineer, Medtronic
Marketing Manager, Medtronic
Senior Master Black Belt and Senior Program Manager, DFSS / DRM, Medtronic
Senior Regulatory Affairs Manager, Medtronic
Senior Systems Engineer, Medtronic
Senior Quality Engineer, Medtronic
Senior Quality Engineer, Medtronic
Regulatory Affairs and Compliance Officer, MicroAire Surgical
Account Executive, Minnetronix
VP of Sales and Marketing, Minnetronix
Senior Industrial Liaison, MIT
Business Manager, Modulated Imaging
CEO, Modulated Imaging
Board Member, National Research Network
CEO and Founder, Nexeon MedSystems
Plant Manager, NIPK Electron
Professor, North Carolina Central University: School of Law
CEO, NovaBay Pharmaceuticals
CSO, NovaBay Pharmaceuticals
Director Of Inorganic Chemistry, NovaBay Pharmaceuticals
Representative, NovaBay Pharmaceuticals
Representative, NovaBay Pharmaceuticals
Svp New Business Development, NovaBay Pharmaceuticals
Senior Vice President of Product Development, NovaBay Pharmaceuticals
VP of Advanced Care Business Unit, NovaBay Pharmaceuticals
Manager Systems Integration, Novartis Molecular Diagnostics
CFO, OSI
Director, OSI
Senior Director of Engineering, Omnicell
Managing Manager, OmniPort
Executive Director of R&D: Functional Bracing and Soft Goods, Ossur
Executive Leader: Supply Chain and Strategic Sourcing, Ossur
CEO, Ouron Technologies Inc.
Founder, Panaceon
Vice President of Strategy and Corporate Development, Parasoft
Sales Manager, Pg Drives Technology
Sales, Philips Respironics
Chief Financial Officer, PhotoThera
President, PlenStat
Vice President of Business Development, PlenStat
CEO, Po Tong Technologies
CEO, Presbia
CTO, Presbia
Director of Operations, Presbia
Mechanical Design Engineer, Presbia
Marketing Manager, Presbia
Regulatory and Quality Affairs Officer, Presbia
Owner, Prestige Health Care Technologies
President and CEO, Product Creation Studios
Vice President, Product Creation Studios
Director of Open Innovation, Psion
Compliance & Regulatory Affairs Officer, Pulsecorp
Regulatory & Compliance Officer, Pulsecorp
Senior Leader, Electrical Engineer, Qigen
Senior Corporate Recruiter, Quidel
President and CEO, Rainmaker Technology, Inc.
CIO, ResMed
COO, Restech
VP of Operations, Rexanto
Group Controller, Sakura Finetek USA
Marketing Director, Sakura Finetek USA
Senior Vice President, Sakura Finetek USA
CEO, Sensiotec Inc.
Key Account Manager, Smiths Medical
CEO, SMS+
Quality Assurance/Regulatory Manager¸ Southern Implants
Federal AM Navy & USMC, SPAWAR
CFO, Spinofix Inc
Engineering and Quality Specialist, Spinofix Inc.
President and CEO, Spinofix Inc
Registered Nurse, St. Mary’s Hospital
Executive Director, Stanmore Capital
Managing Director, Stanmore Capital
Senior Design Engineer, St. Jude Medical
Senior Project Manager, Sterling Medical Devices
President, Sterling Medical Devices
Supplier Development Manager, Stryker
CEO, StyledWel
President/COO, SurgLine
President of Orthopedics, SurgLine
Chairman, Syncardia
HW Electrical Engineer, Tandem Diabetes
Managing Director, Torrey Pines Investment
Lead Auditor/Sales and Business Development Manager, TUV Rhineland
Technical Manager, Medical Tests, TUV Rhineland
Executive, UCLA
Surgeon, United States Air Force
Research Scientist, UCSD
Senior Development Engineer, UCSD
Licensing Officer, UCSD
Assistant Director, Life Science Licensing, UCSD
Researcher, University of Michigan
Professor, University of California, Santa Cruz Extension
Deputy Director, University of Chicago
Associate Professor, University of Illinois at Chicago
Visiting Research Assistant Professor, University of Illinois at Chicago
Research Assistant, University of Mississippi Medical Center
Biomedical Engineer, University of Southern California
Co-Founder, VacuPractor
Professor, Vanderbilt University
Senior Manager, Translational Research, Varian Medical Systems
Vice President of Product Development, VinnComm
VP of Marketing and Business Development, Vivonotics
Director, Financial Planning & Analysis, Volcano Corporation
Direct RA- QA, Warne-Franklin
Field Marketing Manager, Wind River
Product Manager, Test Management, Wind River
Software Architect, WorldHeart Corp
Director Sales Operations, Zimmer

Conference Day 1: Thursday, June 7, 2012
7:00 am
Continental Breakfast & Registration
8:00 am
Chairs' Welcome

David M. Cronin, Director, Cognition Corporation
Cognition
8:15 am
Is it a Phone? Is it an App? Or is it a Device? Navigating Guidance on the Evaluation of New Tech
  • Defining software is becoming a major conversation across the industry, and includes issues of data collection, intent and function
  • Companies are coming under increased scrutiny because of the nature of their software, and some have already come under fire for misclassifying.
  • The FDA released guidelines to address these issues in record time- make sure that you know the rules and regulations surround software by learning from this expert panel!
Moderator:
Arundhati Parmar
, Bureau Chief, MedCity News
Dan Sterling, President, Sterling Medical Devices
Mathew Johnson, Chief Executive Officer/Founder, Inventor of Phrazer, GeaCom
Sterling Smartware Solutuions
Speaker opportunities available
9:00 am
Enhancing Medical Device Design Development through DRM/DFSS Principles

Dr. Eric Maass
, Senior Master Black Belt and Senior Program Manager, DFSS / DRM, Medtronic
Cognition
9:45 am
Morning Refreshment & Networking Break in Exhibition Space
Talk with your peers; enjoy some light refreshments all while learning about some new and exciting services and technologies from our exhibitors


Sponsored by:
ISIS
10:15 am
Interoperability and Exchange: Promoting Safety and Compliance
  • Learn about effectively communicating healthcare information between devices and settings in this cross disciplinary panel
  • Medical devices are subject to multiple standards that are not always in accordance with one another: learn from leaders about how to effectively navigate these criteria
Anette Asher, Board of Directors, Sharp Healthcare & HIMSS
Christopher Lindop, Interoperability Manager, GE Healthcare

11:00 am
Protecting Against Threat: Security Across Connected Devices
  • Security - it's more than about HIPPA
  • Malware concern around connected devices
  • Hardware features can be used to lower threat
  • Software and Hardware combinations to lower threat
Michael Preston Taborn, Platform Architect, Medical Segment, Embedded & Communications Group, Intel Corporation
Intel
11:45 am
Luncheon Presentation: Delivering Safe, Reliable, and Compliant Medical Device Software

Few embedded devices have a more direct personal impact on users than medical devices. They control the heart rate of pacemaker users, manage the flow of life-saving medication in fragile patients, and provide continuous home monitoring for the chronically ill.

Embedded software is a vital element in the majority of today's medical devices—and when it fails, disastrous results follow. As device software grows in functionality and complexity, it becomes increasingly difficult to verify that it works correctly. Making matters worse, market dynamics force device manufactures to shrink their product development cycles, leaving less time than ever for comprehensive testing programs.
  • Effectively develop and test sophisticated medical devices while remaining compliant with safety standards and certifications
  • Increase the performance and reliability of your devices without increasing your project budget or missing your market window
  • Address testing challenges and what you can do today to improve the quality of software in your medical devices
Amir Raz, Product Manager, Test Management, Wind River
Wind River
1:00 pm
Unpacking the America Invents Act: Implications for the Medical Device Industry
  • Practical implications of the legislation: how will this impact business's day to day
  • Post-Grant Review; absorbing the new work this brings
Dinesh N. Melwani, Attorney, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
Leslie I. Bookoff,
Attorney, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
Nena Bains, Vice President, Intellectual Property & Legal Affairs, Asthmatx, Inc., a Boston Scientific Company
Finnegan
1:45 pm
Shrinking Devices: Miniaturization and Device Design
  • To address growing patient needs, medical devices have been shrinking- which will allow many medical procedures and treatments to come out of the hospital and into the home: saving patients and hospitals millions
  • Hear about the impact this is having on portability, and how this will change areas like emergency medicine forever
Georgette Belair, Executive Director of R&D: Functional Bracing and Soft Goods, Ossur
Lucia Buehler, Group Product Director, AlphaTec Spine
Rob Pecsar, Vice President of R&D, CareFusion

Sponsorship opportunities available
2:30 pm
Meeting the FDA's Requirements for Design Control
  • Understanding the Fundamental Requirements of Design Control as Prescribed by FDA
  • Identify Key Steps Associated with Design Control
  • The Importance of the Design History File (DHF)
  • The Importance of the Device Master Record (DMR)
  • Design Validation versus Design Verification
  • When to Hold Design Reviews
  • Current FDA Enforcement Actions
Dr. Christopher J. Devine, President, Devine Guidance, & Former Senior Manager of Corporate Quality Assurance, Boston Scientific

3:15 pm
Best Practices in Clinical Trial Development: International and Domestic Regulatory Perspectives

Laurie Weberman-Roussel, Senior International Counsel, Boston Scientific Corporation
Zachary Woodson, Senior Regulatory Affairs Manager, Medtronic Vascular

Sponsorship opportunities available
4:00 pm
Afternoon Refreshment and Networking Break in the Exhibition Lounge
Talk with your peers; enjoy some light refreshments all while learning about some new and exciting services and technologies from our exhibitors
4:15 pm
Industry Workshops
  • Choose 2 half hour long workshops to attend, and join other industry leaders as they host in-depth discussions on a variety of topics.
  • After 30 minutes, attendees will be given the opportunity to switch rooms and hear from a different industry leader on a whole new topic
Table 1 Sponsored by: Cognition
Cognition
Table 2 Delivering Safe, Reliable, and Compliant Medical Device Software, (Continued)
  • Unpack some of the hot button issues brought up at the luncheon talk in this intimate, workshop setting!
Amir Raz, Senior Product Manager, Test Management, Wind River

Sponsored by:

WIND RIVER
Wind River
Table 3 Sponsored by: TUV Rheinland
This table will have different topics for session A and session B. Please choose one.

Session A: Sorting out the deadlines for Medical Equipment tests to 60601- 3rd Ed.
Different countries and regions have different requirements and deadlines for bringing products into compliance with 60601-1 3rd Edition. This roundtable will lay out the deadlines and share details of the requirements in the USA, Canada, Europe, and other markets.

Session B - How to document Risk Management in order to meet 60601-1 3rd Ed.
Abstract - ISO14971:2007 is commonly used as the risk management standard for electrical medical equipment. This roundtable will examine the best ways to document your conformity to both ISO14971 and IEC 60601-1 3rd. Ed.

Speaker:
Dale Hallerberg,
Technical Manager, Medical Product Testing, TUV Rheinland

TUVRheinland
Table 4 Sponsored by Parasoft
This table will have different topics for session A and session B. Please choose one.

Speaker:
Wayne Ariola,
Vice President of Strategy, Parasoft

Session A: A Comprehensive Defect Prevention Strategy for Medical Device Software
Session B: Policy Driven Software Development for Medical Device Software

Parasoft
Table 5: Open Innovation in the Mobile Medical Device Space

Learn about Open Innovation and how it can deliver benefits in the mobile medical device space. Open innovation is a growing phenomenon across various markets, utilized by organizations as diverse as P&G, NASA, Dell, GSK and Life Technologies. It’s about bridging internal and external resources and acting on those opportunities to bring better innovation to market faster. In addition to "better innovation", benefits can include faster development cycles and lower costs. Let’s discuss how your company might benefit from open innovation with respect to development efforts for mobile medical devices.

Speaker:
Todd Boone, Director of Open Innovation, Psion
Psion
5:00 pm
Day One Closing Remarks and Cocktail Reception (in the Exhibition Space)

Sponsored by:
Cognition
Conference Day Two: Friday, June 8, 2012
8:30 am
Continental Breakfast & Registration
9:30 am
Chairs' Welcome
9:45 am
Keynote Panel: Fostering New Technology: Do You Have What Partnership Organizations Are Looking For?
  • Crossing the Valley of Death- incubating technology and getting to the next stage of development
  • More than ever it's important to "incorporate the endgame", and be up to date on reimbursement issues
  • How companies are evaluating how meaningful a product is in the lives of future patients
Jeff Hersh, Chief Medical Officer, HealthCare Systems, GE Healthcare
David Hankin
, CEO, Alfred E. Mann Foundation for Scientific Research
Aaron Goldmuntz, Senior Director, Business Development and Strategy, West Wireless Health Institute
10:45 am
Medical Device Innovation: Concept, Product, Practice: Case Studies in Cardiovascular Innovation
  • Cardiovascular disease is the leading cause of death in the U.S. Why and how has this spawned numerous medical device therapeutic strategies, companies and products?
  • Understanding basic mechanisms of disease, therapeutics, and technology will ultimately reduce risk. 
  • Understanding timing/costs of development, regulatory and reimbursement approval are key to a successful business strategy
  • How important are regulatory and reimbursement strategies? When should these enter the equation
  • How should you bring forward platform technology? Do you cross-over to non-medical applications? How does this alter business strategies?
  • The role of the market and understanding of its complexities  - vital to an effective business strategy.  Should a "low-hanging fruit" market opportunity trump a higher return complex opportunity or vice versa?  Can one be too far ahead? What are the consequences?
Dr. Marvin Slepian, Co-Founder and Chairman, SynCardia

11:00 am
Morning Refreshments & Networking Break in Exhibition Space

Talk with your peers; enjoy some light refreshments all while learning about some new and exciting services and technologies from our exhibitors
11:15 am
Moving from Concept to Commercialization: Concerns and Issues for Medical Device Startups
  • Understanding the medical device landscape: how do companies set themselves apart
  • Raising capital- who, what, where, when and how
  • Get a better understanding of the accelerator model: what’s viable and what isn't
  • Facing the regulatory challenges ahead and building a supportive infrastructure
Skip Coomber, Angel Investor; Chairman, HEROware
Mark Bates, Chief Executive Officer and Founder, Nexeon MedSystems
Pete Gonzalez, Systems & Services Certification, Medical Auditor & Specialist / Healthcare Division, SGS
12:00 pm
Luncheon Presentation
1:00 pm
Mobile Health: the Convergence of Inexpensive Medical Technology, Smartphones, and Patient Engagement. A New Paradigm?
  • Learn from a case study on how one company is putting medicine back into the patients hands, and using mobile health to engage them as an agent of their own care
Adam Schlifke, MD, MBA, Anesthesiologist, Kaiser Permanente; Entrepreneur, Panaceon & IdeaMed; Mentor, Blueprint Health

Sponsorship and speaker opportunities available

1:45 pm
Planning Ahead: Integrating Strategic Sourcing into Your Early Development Process
  • Sharing insight and information between design, engineering and partners is a vital step to take early on: gain skills for ensuring communication throughout your product's lifecycle
  • Use these skills to promote innovation, accelerate time to market and reduce cost
Sponsorship and speaker opportunities available
2:30 pm
Conference Adjourns
Light Refreshments and Networking Opportunities available in Exhibition Space
Speaker Biographies
Mark Bates, Chief Executive Officer and Founder, Nexeon MedSystems

Dr. Bates has and academic background as professor of Medicine and Surgery at West Virginia University. He has performed thousands of cardiovascular interventional procedures and authored over 100 manuscripts and book chapters. He founded a large vascular center of excellence in Charleston West Virginia that is internationally recognized for bringing vascular surgeons, radiologists, cardiologists and vascular medicine specialists all together as a team with a patient centered focus. He has over 50 issued and pending US patents and has been involved in device development for over 2 decades. His carotid filter patents were acquired by Boston Scientific and Flow Control/ Reversal patents acquired by Gore Medical. Abbott holds a license for his helical SFA bistable stent design specific to bioabsorbable applications and CeloNova BioSciences now owns his other stent patents. He is currently on the Board of CeloNova and has been on the scientific advisory board for multiple publically traded as well as start-up companies. Dr. Bates founded one of the first medical device accelerator companies in the US (Paragon Intellectual Properties) in 2004. The $30 million Dr Bates raised to start the accelerator company included support from the Compass group at Guidant corporation along with Angel investors and a coloration agreement with SurModics. Paragon merged the subsidiaries into Nexeon MedSystems, Inc. in 2008 and subsequently the company has enjoyed one successful spinout and presently has 8 additional companies at various stages of development

Georgette Belair, Global Platform Leader – International Infusion Products, CareFusion Corporation

Georgette Belair is currently responsible for the global infusion product platform: including managing the portfolio of development projects to maintain and improve all products and systems for the global market. Georgette has led various roles in CareFusion Leadership Corporation (formerly Cardinal Health Clinical and Medical Products), including the role of Vice President, Program Management. Her team of Program Managers and Directors led the development of innovative new products across 4 business units. Her group was responsible for committing to and delivering against scope, schedule and budgets for programs up to $40 million costs each. Her most recent accomplishment was the successful consolidation of the worldwide Infusion R&D organization, including planning and executing the transfer plans for products, tools, and project, from a UK site to the US headquarters, saving the organization US$11MM per year.

Georgette led the organization and implementation of a business-level PMO in 2008 in order to drive alignment and optimize the success of product execution and launch. In addition to driving an accountable and transparent PMO, Georgette led the implementation of the Phase-Gate governance, optimizing portfolio-based business decisions along the development timelines. Her starting roles at CareFusion included implementing Design-for-Six-Sigma (DfSS) tools into their Global Development Process, and sponsoring the creation of company-wide training material and implementation plan DfSS across CareFusion.

Prior to joining Cardinal Health/CareFusion, Georgette led the Deployment and Integration of Design Excellence at Ethicon Endo-Surgery (EES), a Johnson & Johnson Company. Georgette has long-held significant leadership roles across industries, including JnJ, GE Lighting and Pilkington North America. Her career history includes major product development efforts, engineering projects, and manufacturing leadership, as well as major company-wide implementations of new systems like OpEx, Design Excellence, Stage Gate, and Quality Management systems. In addition to her Bachelor of Mechanical Engineering and Masters in Business, She has earned Black Belt and Master Black Belt Certification in multiple organizations over a decade. Georgette is a published author, “Implementing Design for Six Sigma” (Belair/O’Neill; ASQ Quality Press, 2006).

Leslie I. Bookoff, Partner, Finnegan, Henderson, Farabow, Garrett & Dunner LLP

Leslie I. Bookoff is a partner in Finnegan, Henderson, Farabow, Garrett & Dunner LLP’s Washington, DC office. His practice involves most aspects of patent-related work with an emphasis on the medical device field. He provides a full range of patent services to clients with a particular focus on developing patent strategies in concert with the client’s business goals. He has considerable experience building and managing patent portfolios, from start-ups to larger companies, and in litigating patent disputes, especially those in the medical device industry.

Mr. Bookoff analyzes patent portfolios of competitors to counsel clients regarding acquisition of technology, licensing, contemplated products, and potential design-around options. He studies competitor products to advise clients on enforcement of their patent portfolios and often prepares validity, infringement, patentability, and clearance opinions. He represents clients in due diligence investigations during investment transactions and prepares and prosecutes foreign and domestic patent applications, including practice according to the Patent Cooperation Treaty.

Mr. Bookoff's technical expertise extends to diverse technologies in the mechanical and electro-mechanical fields with a particular emphasis on medical device technologies, including catheters, endoscopic and urologic devices, and implants for treatment of heart-related ailments, biopsy instruments, neurological implants, spine treatments, and blood testing devices. He directed the patent strategy for a small medical device company developing novel therapies for mitral regurgitation and left ventricular dysfunction, including growing a worldwide portfolio of over 100 patents and patent applications, and representing the company in patent interferences and in due diligence investigations during investment transactions. He handled the patent work for a company that developed a drug coated balloon catheter, from the company’s inception as a start-up to its recent purchase four years later for over $300 million. Mr. Bookoff regularly presents at medical device industry meetings and has been quoted in The Gray Sheet, a significant publication in the medical device community.

Mr. Bookoff received his J.D. from the University of Pennsylvania and completed his undergraduate studies in mechanical engineering at the University of Maryland. He is admitted to practice before the District of Columbia, Maryland, and the U.S. Patent and Trademark Office.

Todd Boone, Director of Open Innovation, Psion, Inc.

Todd is a seasoned leader that has delivered strong results across a variety of roles within the high-tech industry, including; general management, sales, product management, product marketing and marketing communication. This diverse skill set is rounded out by international assignment experience as the general manager based in Singapore looking after Psion’s South East Asia operations.

His current role is that of a change agent – breaking Psion out of a traditional commodity intensive product offer into a new differentiated strategy that builds on the company’s strengths and expands its addressable markets. This transformation is centered on the incorporation of Open Innovation principles into Psion – a principal that invites partners to build on top of Psion’s modular platform architecture to come up with customized products that are market focused and highly differentiated. The strategy is starting to reap rewards and Todd continues to drive its execution for Psion.

David M. Cronin, CEO, Cognition Corporation

Mr. Cronin has worked in the product development world for over 20 years. He has a Bachelor of Science in Electrical Engineering and a High Tech MBA, both from Northeastern University in Boston, MA. Mr. Cronin has worked in both the engineering and marketing fields and is currently responsible for conducting applications and business development at Cognition Corporation. He assists companies who are implementing Systems Engineering, DFSS, lean, and other product development improvement initiatives and has experience in such industries as medical devices, automotive, defense/aerospace, consumer electronics, and services.

Christopher Joseph Devine, Ph.D., President, Devine Guidance International, Inc

Dr. Christopher Joseph Devine is the President of Devine Guidance International, Inc., a consulting firm specializing in providing solutions for regulatory compliance, quality, supplier management, and supply-chain issues facing the medical device industry. Previously, Dr. Devine spent 14-years with Boston Scientific, a Fortune 500 medical device manufacturer. Additionally, Dr. Devine is the author of Devine Guidance, a weekly blog focusing on the understanding of regulations mandated by the FDA and other regulatory bodies; and published by the Medical Device Summit, an e-magazine. Furthermore, Dr. Devine has recently authored two books providing guidance on complying with the FDA’s Quality System Regulation and the European Medical Device Directive. Furthermore, Dr. Devine has 33-years of experience in quality assurance, regulatory affairs, and program management. He is a senior member of the American Society of Quality (ASQ), a member of Regulatory Affairs Professionals Society (RAPS), a member of the Project Management Institute (PMI) and resides on several editorial and technical advisory boards. Dr. Devine received his doctorate from Northcentral University, with his doctoral dissertation entitled, “Exploring the Effectiveness of Defensive-Receiving Inspection for Medical Device Manufacturers: A Mixed-Method Study.” Prior to launching his professional career, Dr. Devine served honorably as a United States Marine.

Dale Hallerberg, Technical Manager - Medical Test, TÜV Rheinland North America

Dale Hallerberg is the Technical Manager for Medical Product Testing at TÜV Rheinland of North America. Dale obtained his BS in Electrical Engineering from the University of Illinois in Champaign, IL. He has over 25 years of experience in product safety testing and electrical safety research. Dale is a member of the AAMI Electrical Section, and is active on the IECEE Risk Management Task Force. He is also part of the IEC 60601-1 third edition Amendment 1 development team.

Jeff Hersh PhD, MD, RAC, Chief Medical Officer, GE HealthCare Systems

Job Title:
- Chief Medical Officer, GE HealthCare Systems
How long in current role:
- Since 2010
Number of years with GE:
- 2 years
Numbers of years in healthcare industry:
- 20+ years
Previous roles:
- Global Medical Director of Medical Safety, Boston Scientific
- Chief Medical Officer MA-1, NDMS
- Nationally Syndicated Newspaper Columnist, "What's up doc?"
- Attending Physician, Emergency Rooms for 20+ Years
- Previous Faculty Appointments @ Yale, Dartmouth, Cornell, Tufts, U Mass, & Harvard

Education:

- MD, University of Miami Leonard M. Miller School of Medicine
- PhD Theoretical Physics, Yale University
- MS Electrical Engineering, George Washington University
- BS Physics, Rensselaer Polytechnic Institute
- BS Mechanical Engineering, Rensselaer Polytechnic Institute

Interests:

- Paragliding, Running, Swimming, theoretical analysis of the fundamentals of time
- Extensive industry experience as the Global Director of Medical Safety for Boston Scientific and presently the Chief Medical Officer for Healthcare Systems for General Electric HealthCare.
- Extensive clinical experience with a history of over 20 years as a practicing physician and Board Certifications in Internal Medicine, Pediatrics, Emergency Medicine and Disaster Medicine.
- Currently an intermittent federal employee as the Chief Medical Officer for the Massachuesstes-1 Disaster Medical Assist Team under the National Disaster Medical System of Health and Human Services.
- Extensive academic experience with previous faculty appointments at Harvard, University of Massachusetts, Tufts, Cornell, Dartmouth, Yale and others. I also served as Editor-in-Chief of the American Journal of Clinical Medicine, as well as a reviewer for several journals. I was also a member of the U. Mass. IRB for several years.
- Extensive clinical trial experience including a $319k NIH grant, as well as PI of multiple studies.
- Extensive regulatory experience, including being RAC by RAPS and authoring and lecturing on multiple regulatory topics relating to the medical device industry.

Mathew Martin King Johnson, CEO, Geacom

Mathew Martin King Johnson, is the CEO/founder of GeaCom and inventor of Phrazer®. He is an internationally recognized innovator with experience in both startup and established businesses. Prior to GeaCom Mat was top management of the Western Hemisphere Division of Kawaguchi Robotics (a division of Kawaguchi), president of Veldhiezen Group Inc. and contracted with several fortune 500 companies such as Cargill, Honeywell, and Medtronic. He is the recipient of the 20 Under 40 award, Minnesotan's on the Move and multiple Economic Development awards. His current invention (Phrazer® System) has been awarded the Minnesota Cup, the International Edison Award, Tekne, the international Value Chain Award along with numerous other recognitions. Mat has also received recognition in the development of advanced video streaming technologies, advanced robotics, development of leading SAAS channel management solutions, implementation of global medical technologies and is a versed in the application of communication theory.

Mat has shown a proven ability to assemble world class teams of experts and partners to bring unprecedented levels of expertise to apply technology, resulting in a strong viable businesses comprised of skilled professionals who are global leaders in their respective fields. His experience with startups, in a wide spectrum of economic times, has informed him on adapting to ever changing business environments. Regardless of the level of resistance or complexity, Mat has a reputation for honorable dealings. He is a member of the Grass Roots Innovation Team (GRIT) and is actively involved with many leading technology companies providing him a broad and up to date knowledge of technological advances and market changes. Mat is also a Saint Scholastica College Board Trustee.

On a personal level Mat is driven to help provide equity in society wherever possible and is motivated by a deep interest in improving the human condition. Finding innovative solutions to societal challenges is a passion. He sees his work with GeaCom as part of a moral imperative and believes stronger understanding and the proper use of Communication Theory is a vehicle for global improvement. As a youth, he grew up between the Twin Cities area and International Falls and has enjoyed extensive travel. Mat participated in Division 1 and pro hockey, enjoys outdoor activities and spending time with family.

Dinesh Melwani, Attorney, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

Dinesh Melwani works with start-up and established companies to develop comprehensive patent strategies in concert with their business goals. He focuses on developing patent portfolios, securing freedom-to-operate for new technologies, positioning intellectual property to maximize investment and acquisition opportunities, and helping clients maintain an edge over competitors. Mr. Melwani also studies competitor patent portfolios to counsel clients on contemplated products and potential design-arounds.

Mr. Melwani manages the U.S. and international patent portfolios for a number of clients. He has extensive experience in evaluating potential acquisitions, conducting due diligence investigations, and assisting clients develop revenue streams from licensing their technologies. Additionally, a significant portion of Mr. Melwani’s practice is devoted to patent litigation. His litigation practice includes both district court actions and interference proceedings before the U.S. Patent and Trademark Office (USPTO).

Mr. Melwani works with a variety of mechanical and electro-mechanical technologies. In addition, he has particular experience with medical devices, including minimally invasive surgical instruments, implantable electrical stimulators, biopsy devices, skin treatment devices, brachytherapy devices, cardiac therapies, obesity treatments, needle guards, and respiratory treatments.

Prior to joining Finnegan, Mr. Melwani was a patent examiner at the U.S. Patent and Trademark Office. As an examiner, he handled U.S. and international patent applications in various technologies, including closure fasteners, sealing devices, jewelry, and business methods. He received his J.D. from Georgetown University Law Center and completed his undergraduate studies in mechanical engineering at the University of Florida. He is admitted to practice before the District of Columbia, Florida, and the U.S. Patent and Trademark Office.

In addition, Mr. Melwani is an adjunct professor at the Howard University School of Law, where he teaches courses on patent law. Mr. Melwani also frequently lectures and authors articles on areas relating to patent law and the medical device industry.

Amir Raz, Senior Product Manager, Test Management, Wind River

Amir has over 20 years of experience in product management, marketing and business development, bringing with him background which combines both software testing experience as well as domain expertise in embedded systems. During his career Amir developed compilers and device drivers for Motorola chipsets, lead product management and marketing teams at Sun Microsystems and Mercury Interactive, and drove market development and partnerships at Cisco. Amir holds a B.Sc. in Computer Eng. From the Technion, Israel Institute of Technology.

Laurie Weberman-Roussel, Senior International Counsel, Boston Scientific Corporation

Laurie Weberman-Roussel is a Corporate in-house lawyer specialized in the International field with a strong background in EU legislation and over 15 years in the Medical Device industry.

Dual education/upbringing - Holds Law degrees in France and in the United States (New York).

Before joining BSC in 1996, experience includes IT and Connector industries as well as Pharmaceutical.

Joined BSC as their in-house counsel in Europe supporting functions such as Clinical, Regulatory, Compliance, Marketing and general Contract matters and remained in Europe until 2007 when she relocated to the United States with her family (in San Diego).

Current areas of focus include Clinical, Regulatory and Compliance matters in the U.S and International regions.

Marvin J. Slepian, MD., Co-Founder, Chairman, Chief Scientific and Medical Officer, SynCardia Systems, Inc.

Marvin J. Slepian, M.D. is Professor of Medicine (Cardiology), Director of Interventional Cardiology and Director of the Tissue Engineering Lab at the University of Arizona. In addition, Dr. Slepian is Co-Founder, Chairman and Chief Scientific and Medical Officer of SynCardia Systems, Inc.

Dr. Slepian has founded numerous medical device companies, including Focal (NASDAQ-traded, acquired by Genzyme), Endotex, Angiotrax and Hansen Medical, and has served as acting CEO and Board Member of several medical device startups. Additionally, Dr. Slepian has conducted extensive research, development and pre-clinical investigation of novel cardiovascular therapeutic methods and devices, and is the holder of more than 25 issued and 41 filed patents.

Dr. Slepian received his B.A. degree from Princeton University and a Medical Doctor degree from the University of Cincinnati College of Medicine.  He completed his residency in internal medicine at New York University School of Medicine/Bellevue Hospital where he was also Chief Resident.  In addition, Dr. Slepian was a Clinical and Research Fellow in the Cardiology Division of the John Hopkins University School of Medicine and participated in a second fellowship in interventional Cardiology at the Cleveland Clinic Foundation. He also received additional post-doctoral training at Washington University and Massachusetts Institute of Technology.

Michael Preston Taborn, Platform Architect, Medical Segment, Embedded & Communications Group, Intel Corporation

Michael is presently a Platform Architect for the Medical Segment within the Embedded and Communications Group inside Intel Corporation. His responsibilities include investigating and understanding usage models within the medical market and influencing architectural and product planning for future Intel products that can serve the medical market. Previously within Intel, Michael was a Component Debug Engineer on the Atom processor. Prior to Intel, Michael spent several years as an IC design and verification engineer with IBM, Motorola, and AMD. Michael has a BSEE from The University of Texas at Austin. 8 Patents, 5 Conference Publications, 6 Technical Disclosures and is a member of IEEE.

Pending Registrations
No Registrations Pending
    register now
    Healthcare
    life sciences
    emerging technology
    Finance Events
    Sponsor
    Request More Information
    Join Our Mailing List